Loss of LARP4B, an early event in the tumorigenesis of brain cancer?

Sarah P. Blagden(Churchill Hospital), Utz Fischer(University of Würzburg), Cornelius Schneider(University of Würzburg)

Translational Cancer Research

November 1, 2016

10.21037/tcr.2016.11.33

Cited by 3

Related Papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

|Nature reviews. Cancer|2015|1.4k

Many cuts to ruin: a comprehensive update of caspase substrates

|Cell Death and Differentiation|2003|1k

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

|The Lancet|2019|223

Performance status score: do patients and their oncologists agree?

|British Journal of Cancer|2003|222

La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs

|eLife|2017|201